Breedlove Robert Charles 4
4 · Phathom Pharmaceuticals, Inc. · Filed May 21, 2025
Insider Transaction Report
Form 4
Breedlove Robert Charles
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-19+33,000→ 33,000 totalExercise: $4.39Exp: 2035-05-18→ Common Stock (33,000 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the shares of common stock on May 19, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.